Traceability is a material risk in polyacrylamide procurement. A sample is screened, a winner is selected, and then the bulk order arrives without a documented connection to what was tested. The batch was different, or the lot number was never recorded, or the person who ran the lab screen left before the order was placed and no one wrote the acceptance criteria down. This guide gives you a four-gate qualification plan, a sample identity table, a same-feed comparison matrix, a plant-trial deviation log, and an incoming-QC checklist that together close every gap between the sample you screened and the bulk material you receive.
The four-gate qualification map
Qualification is not a single test. This guide organizes the buyer’s review into four gates, each tied to a named uncertainty and evidence record. If the buyer omits or combines a gate, record which uncertainty remains and what alternate verification will control it before the order is released.
| Gate | Name | Question answered | Evidence required | Go condition |
|---|---|---|---|---|
| Gate 1 | Baseline | Do we have a documented record of the current process state against which the candidate will be compared? | Incumbent grade, dose, feed characterisation, performance metric and variability range | Baseline record is complete and signed; no comparison will be run without it |
| Gate 2 | Repeatable lab screen | Does the candidate meet or exceed the incumbent on a traceable, same-feed comparison at bench scale? | Sample identity record, lab screen protocol, comparison matrix, shortlisted grades with cost-in-use | At least one candidate meets or exceeds all acceptance criteria; retained sample is secured |
| Gate 3 | Plant trial | Does the lab winner perform acceptably when dosed in the full-scale process at production operating conditions? | Trial quantity, fixed feed and operating conditions, acceptance criteria, deviation log, performance record | Candidate meets acceptance criteria at plant scale with no unresolved deviations |
| Gate 4 | Bulk-lot release | Is the first bulk production lot traceable to the approved grade and sample, and does it pass incoming QC? | Bulk lot COA cross-checked to approved spec, incoming QC result, retained incoming sample | Bulk lot COA passes review; incoming QC within acceptance range; retained sample stored |
Each gate is a decision point, not a formality. A hold at Gate 2 means you do not spend plant time on a candidate that cannot beat the incumbent at bench scale. A hold at Gate 3 means you do not release a bulk order for a product whose plant-scale performance has not been validated. These holds cost time at the gate. They are far less expensive than discovering the same problem after a bulk shipment has been received, unloaded and dissolved into your dosing system.
Gate 1: Baseline and incumbent record
The baseline record is the starting document for every subsequent comparison. Without it, you cannot state whether the candidate is better, equivalent or worse than the incumbent, and you have no grounds to hold a supplier accountable for a performance claim. Not assembling it before the first sample is requested is false economy: a baseline that is reconstructed after a screen has already begun is harder to verify and easier to dispute.
Record these fields before the first sample is requested:
- Process unit and configuration. Belt press, centrifuge, thickener, clarifier, DAF, flotation column. Include the manufacturer, model and capacity where known, because physical geometry affects how a polymer performs and whether a lab comparison is likely to transfer.
- Feed material and characterisation. The feed that will be used for the comparison. For sludge: total solids percentage, volatile solids, source (primary, secondary, digested, mixed). For mining: ore type, slurry SG, feed rate. For water treatment: suspended solids mg/L, pH, conductivity or ionic strength. Record a typical value and the normal operating range, because a candidate that works well on the median feed may be sensitive to the extremes.
- Incumbent product: full grade designation. Include every suffix. A name without its suffix is an incomplete identity. If you do not have the full name, take a photograph of the bag or drum label before the current stock is exhausted.
- Incumbent dose. Active polymer dose in g/t dry solids or mg/L, as a range measured under your normal operating conditions. If your dose varies widely, record the typical and the range; a candidate that matches the median but not the peak may still require a dose adjustment.
- Performance baseline. The actual measured outcome against the parameter you will use to evaluate candidates: cake DS%, effluent TSS, overflow turbidity, settling rate, drag reduction, filter aid consumption. State both the current average result and the minimum acceptable result for your process.
- Operating constraints. Make-up water quality and temperature; solution concentration; maturation time available; mixing system type; any known incompatible chemicals in the feed or dosing system.
This record goes into your qualification file and is referenced at every subsequent gate. If the person running the trial is different from the person who assembled the baseline, hand the baseline record to them explicitly. Do not rely on institutional knowledge that may be incomplete or out of date.
Feed variability belongs in the baseline record. One characterization is one data point. When feed changes by season, upstream process or raw-material source, record the operating range and define in advance which feed states the laboratory comparison must cover. Keep results for materially different feed states separate and apply the buyer-defined acceptance criteria to each state.
Gate 2: Sample identity and retained-sample chain
The second gate opens when the sample or samples arrive. Before any solution is made and any screen is run, complete the sample identity record. The sample identity record lets the buyer compare the approved sample identity with a later lot identity and document any difference. It does not prove that a bulk lot came from the same production batch unless the applicable source records establish that relationship.
| Field | Record | Verify against | Retain how |
|---|---|---|---|
| Supplier and brand | Full legal name and brand as stated on package | Quotation entity | Paper record in qualification file |
| Grade / product designation | Full name including all suffixes from package label | TDS header; quotation | Photograph of label; paper record |
| Physical form | Dry powder, emulsion or solution as received | TDS; order | Paper record; photograph |
| Lot or batch number | As printed on packaging or COA | COA batch field | Paper record; COA filed with sample record |
| COA received | Yes/No; if yes, file number | COA lot matches package lot | Filed COA attached to sample record |
| Sample receipt date | Date received at your facility | Production/report date on COA | Paper record |
| Retained sample quantity | Grams retained from received sample before screening begins | Buyer/supplier-agreed amount sufficient for the planned lab replicates, any re-test, and retained reference; document the agreed quantity before screening begins | Sealed container; labelled with grade, lot, date; stored under the quoted grade’s stated conditions or your buyer-approved plan |
Retain a sealed sample from every screened candidate. If a candidate wins the lab screen and goes to plant trial, the retained lab sample is your reference point for the plant trial material. If the bulk lot later deviates from expected performance, the retained sample is investigation evidence: comparing it against the incoming lot under controlled preparation and test conditions can help characterise the deviation, though it does not by itself establish the root cause.
Same-feed comparison matrix and cost-in-use
The lab screen should compare all candidates on the same feed, in the same test, in the same session where possible, or in matched sessions where the feed characteristics are recorded at each session and confirmed to be within normal operating variation. A comparison made on different days with different feed batches is not a controlled comparison; it is two separate data points that cannot reliably be attributed to polymer performance differences.
A jar test is a relative screening step. EPA training materials describe jar tests as comparing relative treatment effectiveness rather than confirming absolute plant performance, and note that pilot or full-scale checks are needed before operational acceptance. Record that distinction clearly: the jar test tells you the relative ranking of candidates at bench scale on your feed; it does not guarantee that the ranking or the absolute performance values will hold at plant scale under your shear, retention time and equipment geometry. Plan Gate 3 before you expect the jar test to make that decision for you.
| Comparison field | Incumbent | Candidate A | Candidate B | Acceptance threshold |
|---|---|---|---|---|
| Grade / lot | [record] | [record] | [record] | Identity confirmed per sample record |
| Solution prep: concentration (%), water quality, mixing time, maturation time | [record] | [match and record; flag differences] | [match and record; flag differences] | Matched and recorded under the buyer-approved plan; where material conditions differ between sessions, flag results as not directly comparable |
| Feed sample used (date / TS%) | [record] | [must be within normal range] | [record] | Same batch for same-session test; documented range for cross-session |
| Optimum dose (g/t or mg/L) | [record] | [record] | [record] | At or below incumbent dose for equivalent result; or lower cost-in-use at higher dose |
| Primary performance result | [record] | [record] | [record] | Meets or exceeds baseline acceptance threshold at the stated dose |
| Cost-in-use ratio: (candidate unit price × candidate dose) ÷ (incumbent unit price × incumbent dose) | 1.00 (reference) | [calculate] | [calculate] | Buyer-defined before testing: at or below 1.00 for direct replacement, or such higher value as the buyer pre-approves against a measured performance gain |
| Screen result | Reference | Pass / Hold / Reject | Pass / Hold / Reject | All acceptance criteria met; no unresolved hold |
If the supplier discloses a difference in production route between the screened sample and the bulk lot, record that difference and treat it as a requalification question before releasing the bulk order.
Gate 3: Plant-trial acceptance and deviation log
The plant trial is the gate that closes the gap between bench-scale relative performance and full-scale operational reality. It is not a repeat of the jar test on a larger volume. It is a controlled substitution of the candidate for the incumbent under real production conditions, with a documented performance record and a deviation log that captures every observation that differs from the expected outcome.
A jar test does not establish the plant dose or confirm plant performance. The EPA training materials cited in this article call for pilot or full-scale checks before operational acceptance. At the plant trial, record the actual feed conditions, dose, equipment settings and outcomes; where the plant result differs from the bench result, document the observed difference without assigning a cause until a root-cause investigation has been completed.
For the plant trial: fix the feed conditions; document the trial quantity; set acceptance criteria before any candidate is dosed. Use this deviation log during and after the trial:
| Field | Expected (from baseline) | Observed (during trial) | Disposition |
|---|---|---|---|
| Optimum dose at plant | [from baseline / jar test estimate] | [record during trial] | Accept if cost-in-use acceptable; Hold if dose unexpectedly high |
| Primary performance metric | [acceptance threshold] | [record] | Accept if meets threshold; Reject if consistently below |
| Dissolution behaviour | Fully dissolved; no lumps at stated make-up | [record] | Lumps or gels at standard conditions require investigation before bulk order |
| Equipment interaction | No abnormal scaling, fouling or screen blinding | [record] | Any fouling or blinding observation requires root-cause investigation before bulk order |
| Overall trial disposition | Meet all acceptance criteria | [Pass / Hold / Fail] | Hold: repeat or extend trial; Fail: grade removed from shortlist; Pass: proceed to Gate 4 |
A successful plant trial creates decision evidence and the buyer-approved acceptance reference for Gate 4. The approved grade, solution preparation conditions, plant dose and acceptance metrics from Gate 3 become the incoming-QC reference, but that reference is the buyer’s acceptance record, not a supplier specification.
Gate 4: Bulk batch traceability and incoming-QC release checklist
Gate 4 is where a qualification plan makes missing traceability visible. The grade was approved, the PO was issued, the material arrived, and no one checked whether the COA batch number, the product designation and the physical form were consistent with what was tested at Gates 2 and 3. This checklist records the traceability and comparison evidence for each incoming lot.
Run this checklist on every incoming bulk lot, not just the first. The check covers each lot independently; differences between lots are recorded for investigation, not used to draw conclusions about supplier quality from the checklist alone.
| Incoming QC check | Check against | Release condition | Hold if |
|---|---|---|---|
| Grade designation on COA | Approved grade from Gate 2/3 record | Exact match including all suffixes | Grade name differs or is truncated vs approved record |
| Physical form on packaging and COA | Approved form from Gate 2/3 record | Form matches | Form differs from what was screened and approved |
| Lot number on COA vs packing list and physical markings | Shipping documents and bag/drum markings | Lot number matches across COA, packing list and physical markings | Discrepancy between any two of COA, packing list and physical marking |
| COA result table: all rows within TDS specification | TDS specification ranges for the approved grade | Every result within its specification; no row-qualification conflict | Any row outside specification; conclusion inconsistent with result table |
| Incoming dissolution test (where required) | Preparation conditions from Gate 3 approval | Dissolves fully at approved conditions within normal variation | Lump formation or slow dissolution at conditions that worked on the approved sample |
| Incoming sample retained | Buyer/supplier-agreed quantity sufficient to support any re-test; sealed, labelled with grade, lot and receipt date | Sample secured before bulk is put into service | No retained incoming sample; sample collected after bulk has been dissolved |
| Overall incoming release decision | All checks above | Release: all checks pass; material enters service | Hold: quarantine material pending supplier response; do not dissolve or dose pending outcome |
If a bulk lot fails incoming QC, quarantine the lot before dosing begins. Contact the supplier with the specific COA row that failed, the test method you used for the incoming test, and your incoming result. Request a replacement lot COA and, if the discrepancy is not explained by the document, a root-cause explanation and corrective-action statement. ISO guidance for external-provider controls states that the purchasing organisation should define the verification activity and the degree of control based on product risk. A documented incoming-QC plan with a quarantine procedure is one buyer-control record consistent with that risk-based approach; your organisation determines the scope of control that applies to your situation.
When to re-run the qualification cycle
A qualification that was valid for one period is not permanently valid. Several events should trigger a partial or full re-run of the gate sequence, because they break the traceability connection between the approved grade and the current incoming material.
Supplier notification of a production change. If the supplier notifies you that a manufacturing process change has been made — a change to the polymerisation conditions, to the monomer source, to the drying equipment, or to the product plant — treat the first lot produced under the new conditions as a new sample under Gate 2 and Gate 3. The grade designation may be unchanged, but the product is not identical to what was qualified. A notification that says “no change to specification” records the supplier’s stated scope; it does not predict the performance of the first lot produced under the new conditions. Run the jar test against the retained lab sample from the original qualification before committing to a plant trial quantity.
Lot-to-lot performance drift. If your plant operator reports that the same dose that cleared Gate 3 is no longer achieving the acceptance threshold, and the feed conditions are within the documented normal range, pull the retained incoming sample from the current lot and compare it against the retained sample from the approved qualification lot under controlled preparation and test conditions. A difference in dissolved viscosity or flocculation behaviour at the same concentration is a signal warranting investigation; document the preparation conditions, the feed state and any observed differences, then raise a deviation with the supplier and request a cross-lot COA comparison and a re-test on your application. Hold disposition until the investigation is complete.
Extended storage. Use the shelf life stated by the supplier for the quoted grade and form, not a general industry estimate. If material has been stored beyond or near the supplier’s stated shelf life, or if it was stored outside the supplier’s stated conditions, run a dissolution test and a comparison test under your buyer-approved method against material within the stated shelf life before releasing it to plant use. Performance changes at the same dose should be documented, compared and reviewed under the pre-agreed acceptance plan before any disposition is made.
ChinaPAM can propose a traceable sample shortlist and help plan the plant-trial protocol once you supply the application baseline and the incumbent grade. The quotation form includes a field for application details and trial requirements; submit it with your baseline record and we will return a recommended candidate set with sample quantities and an order-specific quote; availability and timing are discussed in the enquiry response once your inputs are received. For background on entity, production scope and certificates, the supplier profile is the starting point.
Get a grade recommendation and trial plan
Tell us the duty, the water or sludge characteristics, downstream equipment, required quantity and destination. We will recommend a candidate and confirm sample options, available documents, lead time and quotation for that order.
Quotation based on grade, quantity and destination · info@chinapolyacrylamide.com · WhatsApp +86 187-3759-0940
Frequently asked questions
Does a passing jar test mean a polymer will work at plant scale?
No. A jar test is a relative screening step that compares candidates under controlled bench conditions. EPA training materials describe jar tests as comparing relative treatment effectiveness and note that pilot or full-scale checks are needed before operational acceptance. A jar test at Gate 2 tells you which candidates are worth the cost of a plant trial at Gate 3. It does not guarantee that the relative ranking or the absolute dose will transfer to your specific process equipment under production shear, throughput and temperature. Run the plant trial before releasing a bulk order.
How much sample do I need for a qualification programme?
The quantity should be agreed with the supplier before sampling begins, and sized to cover the chosen number of lab replicates at each dose point, a retained reference amount sealed and labelled with grade and lot, and the full plant-trial quantity if Gate 3 is included in the plan. The right amount depends on your equipment feed rate, target dose, trial duration and the number of repeats your acceptance plan requires. Agree the quantity in writing so both parties understand what the sample covers before it is sent.
Can we approve a grade without a plant trial if the jar test result is very strong?
No cited source in this article supports using a jar test alone as operational approval. EPA training materials describe relative screening and call for pilot or full-scale checks before operational acceptance. If the buyer’s own controlled procedure permits another verification route, document that route and its acceptance evidence; do not present the jar result itself as full-scale approval.
What if the first bulk lot COA values differ from the screening sample COA?
Compare the two COA result tables side by side. If both lots have all results within the TDS specification, document the observed differences and proceed to the incoming dissolution test before making a release decision. Two in-range results show only that the printed values lie within the printed ranges; they do not explain cause or authorize release. Your pre-agreed acceptance plan governs disposition, not the COA qualification column alone. If the bulk lot result pushes a value outside your acceptance specification — even if the supplier’s COA shows “qualified” — quarantine the lot and request a corrected COA or a replacement lot. Do not approve a deviation from your own specification because the supplier’s qualification conclusion says pass.
Sources
- US EPA — Wastewater training manual (jar-test and scale-up limits). EPA NEPIS archive. Supports: jar tests compare relative treatment effectiveness; pilot or full-scale checks are needed before operational acceptance. Limits: historical training reference; plant-specific acceptance criteria remain user-defined.
- US EPA — Field manual with polymer solution preparation example. EPA NEPIS archive. Supports: a 0.1 percent dry-polymer solution is one documented test example; concentration, water, mixing and age must be recorded for comparability. Limits: historical method example, not a universal ChinaPAM preparation specification.
- ISO 9001 Auditing Practices Group — Guidance on External Providers (ISO/TC 176 APG). PDF. Supports: procurement qualification should define verification and acceptance evidence before the supplier order is released; the degree of control should reflect product risk. Limits: auditing guidance for ISO 9001 procurement controls; does not certify ChinaPAM or prescribe PAM performance.